[1]
2026. Efficacy and Safety of Brodalumab in Participants With Moderate-to-Severe Plaque Psoriasis: The Patient Journey. SKIN The Journal of Cutaneous Medicine. 10, 3 (May 2026), s776. DOI:https://doi.org/10.25251/0qyqmz27.